Health and Human Services News and Research RSS Feed - Health and Human Services News and Research

Researchers reveal key factor in understanding elevated cancer risk linked to gene therapy

Researchers reveal key factor in understanding elevated cancer risk linked to gene therapy

National Institutes of Health researchers have uncovered a key factor in understanding the elevated cancer risk associated with gene therapy. They conducted research on mice with a rare disease similar to one in humans, hoping their findings may eventually help improve gene therapy for humans. Researchers at the National Human Genome Research Institute, part of NIH, published their research in the Jan. 20, 2015, online issue of the Journal of Clinical Investigation. [More]

NeoDeck, DataMotion partner for secure messaging of clinical and non-clinical information

FNeoDeck Holdings, Puerto Rico's leading provider of healthcare management solutions, today announced it has partnered with DataMotion, an accredited health information service provider (HISP) supplying email encryption solutions for clinical and non-clinical exchange of protected health information (PHI). [More]
Brain uses separate pathway to recall old fear memories

Brain uses separate pathway to recall old fear memories

People with anxiety disorders, such as post traumatic stress disorder (PTSD), often experience prolonged and exaggerated fearfulness. Now, an animal study suggests that this might involve disruption of a gradual shifting of brain circuitry for retrieving fear memories. Researchers funded by the National Institutes of Health have discovered in rats that an old fear memory is recalled by a separate brain pathway from the one originally used to recall it when it was fresh. [More]
AMRI awarded NIH contract for drug development services

AMRI awarded NIH contract for drug development services

AMRI today announced it received a 10-year federal contract award from the National Institutes of Health for drug development and manufacturing services. This NIH/National Institute of Neurological Disorders and Stroke award will support NIH's Drug Manufacturing and Formulation Program (DMFP), which is a component of the Blueprint Neurotherapeutics Network (BPN). [More]
MRIGlobal awarded $54 million NIH contract to provide support for drug development

MRIGlobal awarded $54 million NIH contract to provide support for drug development

MRIGlobal today announced that it has been awarded a $54 million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the development and manufacturing of drug candidates for ultimate use in human clinical trials. [More]
NIAID awards contracts to support early-stage human clinical trials of infectious disease treatments

NIAID awards contracts to support early-stage human clinical trials of infectious disease treatments

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded contracts to three organizations to support early-stage human clinical trials of investigational infectious disease treatments. The new awards for the Phase I Clinical Trial Units for Therapeutics increases the number of funded organizations under the program from two to three, expanding capacity for conducting early safety testing of novel investigational drugs. [More]
Leading cardiac specialists propose new guidelines for donor heart allocation

Leading cardiac specialists propose new guidelines for donor heart allocation

A group of leading cardiac specialists has proposed new guidelines for the allocation of donor hearts to patients awaiting transplant. The changes are aimed at improving the organ distribution process to increase the survival rate of patients awaiting transplant and posttransplant. [More]
Individualized, patient-centered care needed to treat and monitor people with chronic pain

Individualized, patient-centered care needed to treat and monitor people with chronic pain

An independent panel convened by the National Institutes of Health concluded that individualized, patient-centered care is needed to treat and monitor the estimated 100 million Americans living with chronic pain. To achieve this aim, the panel recommends more research and development around the evidence-based, multidisciplinary approaches needed to balance patient perspectives, desired outcomes, and safety. [More]
Women & Infants Hospital of Rhode Island receives 2015 Women's Choice Award

Women & Infants Hospital of Rhode Island receives 2015 Women's Choice Award

Today it was announced that Women & Infants Hospital of Rhode Island, a Care New England Hospital, has received the 2015 Women's Choice Award as one of America's Best Hospitals for Obstetrics. This evidence-based designation identifies the country's best health care institutions based on robust criteria that consider female patient satisfaction, clinical excellence and what women say they want from a hospital. [More]
Georgia State University awarded contract to improve mental health services for Georgia's youth

Georgia State University awarded contract to improve mental health services for Georgia's youth

Georgia State University's School of Public Health has received a five-year, $800,000 contract from the Georgia Department of Education to coordinate Youth Mental Health First Aid Training (YMHFA) and other professional development efforts designed to improve services for Georgia's youth. [More]

Global Vision Technologies announces addition of new agencies to the FAMCare family

Global Vision Technologies - the leading provider of rapid case management software for human services, is pleased to announce the addition of several new agencies joining the FAMCare family. These agencies are from different backgrounds and disciplines and are leveraging FAMCare to streamline and track service delivery and measure improvement and program effectiveness. [More]
Gamida Cell granted FDA and EMA orphan drug designation for NiCord

Gamida Cell granted FDA and EMA orphan drug designation for NiCord

Gamida Cell, a leader in cell therapy technologies and products for transplantation and adaptive immune therapy, announced today that orphan drug designation has been granted by The US Department of Health and Human Services, The FDA Office of Orphan Products Development (OOPD) for the investigational medicinal product NiCord for the treatment of acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Hodgkin lymphoma and myelodysplastic syndrome (MDS). [More]
Most Americans unaware of the positive benefits of folic acid

Most Americans unaware of the positive benefits of folic acid

Each year, more than four million women in America give birth and 2,600 infants are born with neural tube defects. [More]
Seattle Cancer Care Alliance launches health improvement grant program

Seattle Cancer Care Alliance launches health improvement grant program

Inspired by its Community Health Needs Assessment (CHNA) 2012-2015 report, Seattle Cancer Care Alliance recently launched a health improvement grant program. The new community program addresses specific cancer screening, early detection, and prevention needs for at risk populations in King, Snohomish, and Pierce counties. [More]
Mimedx receives subpoena from Office of Inspector General, HHS

Mimedx receives subpoena from Office of Inspector General, HHS

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that it has received a subpoena from the Office of Inspector General ("OIG") of the Department of Health and Human Services ("HHS") in connection with a civil investigation into matters primarily related to the Company's sales and marketing activities. [More]
PA Department of Aging awarded grant to enhance volunteer programs

PA Department of Aging awarded grant to enhance volunteer programs

The Pennsylvania Department of Aging has received a Performance Improvement and Innovation grant from the U.S. Department of Health and Human Services' Administration for Community Living. The grant of $200,000 will be devoted to assist local APPRISE programs in developing strategic approaches to enhance volunteer programs. [More]
Inovalon announces list of organizations supported through its charitable contributions during 2014

Inovalon announces list of organizations supported through its charitable contributions during 2014

Inovalon Holdings, Inc., a leading technology company providing advanced analytics and data-driven intervention platforms to the healthcare industry, today announced the list of organizations supported through its charitable contributions during 2014. [More]
TSRI scientists awarded $2.3 million grant to find ways to erase traumatic memories

TSRI scientists awarded $2.3 million grant to find ways to erase traumatic memories

Scientists from the Florida campus of The Scripps Research Institute have been awarded $2.3 million from the Department of Health and Human Services of the National Institutes of Health to better understand how memories are stored in the hopes of eventually being able to treat posttraumatic stress disorder (PTSD) by erasing traumatic memories without altering other, more benign ones. [More]

MU, UMSL receive grant to develop behavioral health workforce

The University of Missouri School of Social Work, in partnership with the University of Missouri-St. Louis School of Social Work, has received more than $1 million from the United States Health Resources and Services Administration to expand training to mental and behavioral health professionals throughout Missouri. [More]
UTHealth opens Trauma and Grief Center for Youth

UTHealth opens Trauma and Grief Center for Youth

Children who are having difficulty processing trauma or loss can now turn to the Trauma and Grief Center for Youth at The University of Texas Health Science Center at Houston. [More]